Article thumbnail

Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia

By Nagua Giurici and Giulio A. Zanazzo

Abstract

Controversial issues on the management of empiric therapy and diagnosis of febrile neutropenia (FN) were faced by a Consensus Group of the Italian Association of Pediatric Hematology-Oncology (AIEOP). In this paper we report the suggestions of the consensus process regarding the role of aminoglycosides, glycopeptides and oral antibiotics in empiric therapy of FN, the rules for changing or discontinuing the therapy as well as the timing of the blood cultures

Topics: Article
Publisher: PAGEPress Publications
OAI identifier: oai:pubmedcentral.nih.gov:3103125
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients. Cochrane Database Syst Rev
  2. (2007). Bloodstream infections in neutropenic patients: early detection of pathogen and directed antimicrobial therapy due to surveillance blood cultures. Ann Oncol
  3. Cefepime monotherapy is as effective as cetriaxone plus amikacin in pediatric patient with caner and high-risk febrile neutropenia in a randomized comparison.
  4. Cefepime versus ceftazidime+amikacin as empirical therapy for febrile neutropenia inc hildren with cancer: a prospective randomized trial of the treatment efficacy and cost.
  5. Cost effectiveness of cefepime+netilmicin or ceftazidime+amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Tukey.
  6. Empirical antibiotics against Gram-positive infections for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
  7. Frequency of low level bacteremia in children from birth to fifteen years of age.
  8. (2007). How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children’s hospital. Pediatric
  9. Management of febrile neutropenia: ESMO Clinical Practice Guidelines.
  10. (2000). Oral ciprofloxacin vs intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol
  11. Oral vs intravenous empirical antimicrobial therapy in febrile neutropenic patients receiving childhood cancer chemotherapy.
  12. Randomized control trial comparing oral moxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacina as outpatient therapy in peiatric low-risk febrile neutropenia.
  13. Role of glycopeptides as part of initial treatment of febrile neutropenic patients: a meta analysis of randomized controlled trials.
  14. Supportive care in children.
  15. Timing of specimen collection for blood cultures from febrile patients with Bacteremia.
  16. (2010). Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central lin. Support Care Cancer
  17. Where do we go from here?
  18. Why empirical therapy?